COMPLEXA
Complexa is a clinical-stage platform biopharmaceutical company researching and developing endogenous human cell signaling technologies targeting an array of prevalent inflammatory, fibrotic, and CNS diseases. The company's proprietary technology involves the synthesis and therapeutic applications of endogenous nitro-fatty acids (NFAs) and additional structure/function-related mediators that are designed to treat various diseases. NFAs are cell-signaling agents that regulate major inflammatory s... ignaling pathways (e.g., Nrf2, NFkB, and HSF). Capitalizing on their identification and synthesis of these endogenous signaling mediators, Complexa's technologies act to amplify the existing anti-inflammatory and metabolic signaling mechanisms that promote the resolution and repair of acute and chronic tissue injury and disease. It is headquartered in Berwyn, Pennsylvania.
COMPLEXA
Social Links:
Industry:
Biotechnology Health Care Therapeutics
Founded:
2008-01-01
Address:
Pittsburgh, Pennsylvania, United States
Country:
United States
Website Url:
http://www.complexarx.com
Total Employee:
1+
Status:
Active
Contact:
(412)727-8727
Email Addresses:
[email protected]
Total Funding:
86.95 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS Google Google Cloud Network Solutions DNS Google Cloud Iowa About Cookies
Similar Organizations
Akebia Therapeutics
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
Amicus Therapeutics
Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
CTI BioPharma
CTI BioPharma is a biopharmaceutical company developing oncology products for the treatment of cancer.
Chiasma
Chiasma is a biopharmaceutical company developing oral drugs for the treatment of orphan diseases.
Kodiak Sciences
Kodiak is designing and developing novel therapies for the treatment of retinal disease.
Milestone Pharmaceuticals
Milestone Pharmaceuticals is a drug development company developing small molecule therapeutics for the treatment of cardiovascular diseases.
Promedior
Promedior is a biopharmaceutical company developing novel therapeutics for the treatment of inflammatory and fibrotic diseases.
Rigel Pharmaceuticals
Rigel Pharmaceuticals develops small-molecule drugs for the treatment of autoimmune diseases, cancer and metabolic diseases.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
TARIS Biomedical
TARIS Biomedical is a pharmaceutical company developing therapies for genitourinary system issues.
Current Advisors List
Current Employees Featured
Founder
Investors List
New Enterprise Associates
New Enterprise Associates investment in Series C - Complexa
Pfizer Venture Investments
Pfizer Venture Investments investment in Series C - Complexa
HBM Healthcare Investments AG
HBM Healthcare Investments AG investment in Series C - Complexa
Riverfront Ventures
Riverfront Ventures investment in Series C - Complexa
Jafco Life Science
Jafco Life Science investment in Series C - Complexa
Andera Partners
Andera Partners investment in Series C - Complexa
Jafco Life Science
Jafco Life Science investment in Series B - Complexa
Pittsburgh Life Sciences Greenhouse
Pittsburgh Life Sciences Greenhouse investment in Funding Round - Complexa
Accelerator Fund
Accelerator Fund investment in Funding Round - Complexa
Pittsburgh Life Sciences Greenhouse
Pittsburgh Life Sciences Greenhouse investment in Series A - Complexa
Key Employee Changes
| Date | New article |
|---|---|
| 2020-02-07 | Complexa Appoints Elisabeth Leiderman Chief Business Officer |
